Cary Street Partners Investment Advisory LLC Viatris Inc Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $11,958 - $14,153	1,247 Added 66.94%	3,110 $30,000
Q2 2023 Aug 10, 2023	SELL	$9.02 - $10.29 $1,001 - $1,142	-111 Reduced 5.62%	1,863 $18,000
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $1,729 - $2,304	-188 Reduced 8.7%	1,974 $18,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $18,852 - $24,992	2,162 New	2,162 $24,000

Others Institutions Holding VTRS

# of Institutions

1,091

Shares Held

966M

Call Options Held

2.69M

Put Options Held

2.34M

Vanguard Group Inc Valley Forge, PA

141M
Shares

$1.58 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

92.7M
Shares

$1.04 Billion
0.02% of portfolio
State Street Corp Boston, MA

63.1M
Shares

$707 Million
0.03% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

62.6M
Shares

$702 Million
4.18% of portfolio
Price T Rowe Associates Inc Baltimore, MD

48.8M
Shares

$546 Million
0.07% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account